Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Geldenhuys

Showing results (21-30 of 174) with videos related to

Pageof 18
Sort By:
CNS Drugs|August 30, 2011
Role of serotonin in Alzheimer's disease: a new therapeutic target?Werner J Geldenhuys, Cornelis J Van der Schyf
Expert Review of Neurotherapeutics|July 11, 2009
The serotonin 5-HT6 receptor: a viable drug target for treating cognitive deficits in Alzheimer's diseaseWerner J Geldenhuys, Cornelis J Van der Schyf
Colloids and Surfaces. B, Biointerfaces|March 6, 2012
Effects of gelucire content on stability, macrophage interaction and blood circulation of nanoparticles engineered from nanoemulsionsDaniel Wehrung, Werner J Geldenhuys, Moses O Oyewumi
Expert Opinion on Drug Discovery|December 13, 2012
Designing drugs with multi-target activity: the next step in the treatment of neurodegenerative disordersWerner J Geldenhuys, Cornelis J Van der Schyf
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|December 27, 2008
Polycyclic compounds: ideal drug scaffolds for the design of multiple mechanism drugs?Cornelis J Van der Schyf, Werner J Geldenhuys
ACS Omega|October 12, 2020
Novel Small-Molecule Inhibitor for the Oncogenic Tyrosine Phosphatase SHP2 with Anti-Breast Cancer Cell EffectsZachary Hartman, Werner J Geldenhuys, Yehenew M Agazie
Current Microbiology|August 29, 2016
First Report of the Isolation of the Symbiotic Bacterium Photorhabdus luminescens subsp. laumondii Associated with Heterorhabditis safricana from South AfricaJ Geldenhuys, A P Malan, L M T Dicks
Expert Opinion on Drug Metabolism & Toxicology|April 4, 2012
Novel models for assessing blood-brain barrier drug permeationWerner J Geldenhuys, David D Allen, Jeffrey R Bloomquist
Case Reports in Infectious Diseases|February 27, 2020
Fecal Microbial Transplantation for the Treatment of Persistent Multidrug-Resistant K<i>lebsiella pneumoniae</i> Infection in a Critically Ill PatientV Ueckermann, E Hoosien, N De Villiers, et al.
Biotechnology and Bioengineering|August 5, 1987
An investigation of a fertilizer-tap water medium for mass algal production in outdoor plastic-enclosed systemsD J Geldenhuys, R D Walmsley, D F Toerien
Pageof 18

Showing results (21-30 of 174) with videos related to

Sort By:
Pageof 18
CNS Drugs|August 30, 2011
Role of serotonin in Alzheimer's disease: a new therapeutic target?Werner J Geldenhuys, Cornelis J Van der Schyf
Expert Review of Neurotherapeutics|July 11, 2009
The serotonin 5-HT6 receptor: a viable drug target for treating cognitive deficits in Alzheimer's diseaseWerner J Geldenhuys, Cornelis J Van der Schyf
Colloids and Surfaces. B, Biointerfaces|March 6, 2012
Effects of gelucire content on stability, macrophage interaction and blood circulation of nanoparticles engineered from nanoemulsionsDaniel Wehrung, Werner J Geldenhuys, Moses O Oyewumi
Expert Opinion on Drug Discovery|December 13, 2012
Designing drugs with multi-target activity: the next step in the treatment of neurodegenerative disordersWerner J Geldenhuys, Cornelis J Van der Schyf
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|December 27, 2008
Polycyclic compounds: ideal drug scaffolds for the design of multiple mechanism drugs?Cornelis J Van der Schyf, Werner J Geldenhuys
ACS Omega|October 12, 2020
Novel Small-Molecule Inhibitor for the Oncogenic Tyrosine Phosphatase SHP2 with Anti-Breast Cancer Cell EffectsZachary Hartman, Werner J Geldenhuys, Yehenew M Agazie
Current Microbiology|August 29, 2016
First Report of the Isolation of the Symbiotic Bacterium Photorhabdus luminescens subsp. laumondii Associated with Heterorhabditis safricana from South AfricaJ Geldenhuys, A P Malan, L M T Dicks
Expert Opinion on Drug Metabolism & Toxicology|April 4, 2012
Novel models for assessing blood-brain barrier drug permeationWerner J Geldenhuys, David D Allen, Jeffrey R Bloomquist
Case Reports in Infectious Diseases|February 27, 2020
Fecal Microbial Transplantation for the Treatment of Persistent Multidrug-Resistant K<i>lebsiella pneumoniae</i> Infection in a Critically Ill PatientV Ueckermann, E Hoosien, N De Villiers, et al.
Biotechnology and Bioengineering|August 5, 1987
An investigation of a fertilizer-tap water medium for mass algal production in outdoor plastic-enclosed systemsD J Geldenhuys, R D Walmsley, D F Toerien
Pageof 18